US$ 26.37
dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments cardinal health GLP-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon Advances in GLP-1 receptor agonists
Description
Just because its cheaper doesnt mean its better or safe

A 2025 study examined the effects of both semaglutide and tirzepatide on participants with obesity

Fidler MC, Sanchez M, Raether B, et al

These side effects typically occur when you first start taking the medication or after a dose increase

Furthermore, an enhanced expression of the GLP-1 receptor gene was observed during the osteogenic differentiation process of adipose-derived stem cells, which have the potential for multiple types of differentiation, including osteogenic differentiation

The bigger question is not just whether this drug works